|
Jul 29
|
Perrigo (PRGO) to Report Q2 Earnings: Here's What to Expect
|
|
Jul 29
|
Green Thumb Industries Inc. (GTBIF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Jul 29
|
Shareholders in Perrigo (NYSE:PRGO) are in the red if they invested five years ago
|
|
Jul 26
|
Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 23
|
Does Perrigo (PRGO) Have a Good Growth Potential?
|
|
Jul 10
|
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business
|
|
May 13
|
Understanding Perrigo (PRGO) Reliance on International Revenue
|
|
May 13
|
Perrigo Company plc (NYSE:PRGO) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Perrigo First Quarter 2024 Earnings: EPS: US$0.03 (vs US$0.008 loss in 1Q 2023)
|
|
May 7
|
Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
|
|
May 7
|
Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
May 7
|
Perrigo Co PLC (PRGO) Q1 2024 Earnings: Adjusted EPS Exceeds Expectations Despite Sales Dip
|
|
May 7
|
Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
|
|
May 7
|
Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
|
|
May 6
|
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
|
|
May 6
|
Insights Into Perrigo (PRGO) Q1: Wall Street Projections for Key Metrics
|
|
May 4
|
Perrigo (NYSE:PRGO) Is Due To Pay A Dividend Of $0.276
|
|
Apr 30
|
Perrigo (PRGO) to Report Q1 Earnings: Here's What to Expect
|
|
Apr 25
|
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
|
|
Apr 23
|
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
|